Prostate-specific antigen doubling time as a prognostic marker in prostate cancer

被引：0
|
作者：
James A Eastham
机构：
[1] surgeon in the Department of Urology at Memorial Sloan–Kettering Cancer Center,
来源：
Nature Clinical Practice Urology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There is much debate surrounding the suitability and utility of different prognostic markers in prostate cancer. PSA doubling time (PSADT) has become an important marker in predicting the response to salvage radiotherapy and progression to metastatic disease in men with biochemical failure following local therapy. The methods of calculating PSADT and its use as a prognostic marker are discussed in this review by James Eastham.
引用
收藏
页码：482 / 491
页数：9
相关论文
共 50 条
  • [11] Current applications for prostate-specific antigen doubling time
    Ramirez, Michelle L.
    Nelson, Eric C.
    White, Ralph W. deVere
    Lara, Primo N., Jr.
    Evans, Christopher P.
    EUROPEAN UROLOGY, 2008, 54 (02) : 291 - 302
  • [12] Prostate-specific antigen as a marker of disease activity in prostate cancer
    Partin, AW
    Hanks, GE
    Klein, EA
    Moul, JW
    Nelson, WG
    Scher, HI
    ONCOLOGY-NEW YORK, 2002, 16 (09): : 1218 - 1224
  • [13] Prostate-specific antigen as a marker of disease activity in prostate cancer
    Partin, AW
    Hanks, GE
    Klein, EA
    Moul, JW
    Nelson, WG
    Scher, HI
    ONCOLOGY-NEW YORK, 2002, 16 (08): : 1024 - +
  • [14] Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
    Vickers, Andrew J.
    Savage, Caroline
    O'Brien, M. Frank
    Lilja, Hans
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) : 398 - 403
  • [15] PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME AND DISEASE RELAPSE AFTER RADIOTHERAPY FOR PROSTATE-CANCER
    POLLACK, A
    ZAGARS, GK
    KAVADI, VS
    CANCER, 1994, 74 (02) : 670 - 678
  • [16] Prostate-specific antigen doubling time as a predictor of prostate cancer disease progression and survival.
    Nelson, JB
    Allen, AR
    Hulting, SM
    Isaacson, JD
    Sleep, DS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 395S - 395S
  • [17] Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy
    Moreira, Daniel M.
    Gerber, Leah
    Thomas, Jean-Alfred
    Banez, Lionel L.
    McKeever, Madeline G.
    Freedland, Stephen J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (08) : 741 - 747
  • [18] PROSTATE-SPECIFIC ANTIGEN AS A MARKER OF ADENOCARCINOMA OF PROSTATE
    KELLOKUMPULEHTINEN, P
    NURMI, M
    KOSKINEN, P
    IRJALA, K
    UROLOGICAL RESEARCH, 1989, 17 (04): : 245 - 249
  • [19] Prostate-specific antigen as a marker of prostate disease
    R. Montironi
    R. Mazzucchelli
    F. Algaba
    D. G. Bostwick
    A. Krongrad
    Virchows Archiv, 2000, 436 : 297 - 304
  • [20] Prostate-specific antigen as a marker of prostate disease
    Montironi, R
    Mazzucchelli, R
    Algaba, F
    Bostwick, DG
    Krongrad, A
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2000, 436 (04): : 297 - 304
12345